Search Ontology:
ChEBI
cisatracurium besylate
- Term ID
- CHEBI:3721
- Synonyms
-
- (1R,2R,1'R,2'R)-2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] bisbenzenesulfonate
- (1R,2R,1'R,2'R)-atracurium besylate
- (1R-cis,1'R-cis)-2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] bisbenzenesulfonate
- (1R-cis,1'R-cis)-atracurium besylate
- cisatracurium besilate
- cisatracurium dibenzenesulfonate
- Definition
- The (1R,1'R,2R,2'R)-diastereoisomer of atracurium besylate. Commercial preparations of atracurium are mixtures of 10 stereoisomers, of which cisatracurium generally constitutes about 15%. Cisatracurium besylate is about 3 times more potent than the mixture of atracurium isomers as a neuromuscular blocking agent, and is used as a muscle relaxant for endotracheal intubation, to aid controlled ventilation, and in general anaesthesia.
- References
-
- CAS:96946-42-8
- DrugBank:DB00565
- KEGG:D00759
- Patent:WO9200965
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_part
-
- has_role
-
Phenotype
Phenotype resulting from cisatracurium besylate
Phenotype where environments contain cisatracurium besylate
Phenotype modified by environments containing cisatracurium besylate
Human Disease Model